AIMS: Idiopathic atrial fibrillation describes atrial fibrillation of unknown origin occurring without heart disease. Mortality is considered unaffected by idiopathic atrial fibrillation. We used the long follow-up period (23 years on average) of the Paris Prospective Study I to assess the mortality of idiopathic atrial fibrillation subjects in middle-aged men. METHODS: 7746 working Frenchmen, aged 43-52 in 1967-72, underwent a physical examination plus ECG, answered questionnaires, and provided blood samples. Strict exclusion criteria were used to select idiopathic atrial fibrillation only, and men with known cardiac disease were further excluded from analysis. At 1 January 1994, vital status was unknown for 4.6% of the subjects. The analysis was conducted on the 6722 remaining subjects. RESULTS: Twenty-five subjects had idiopathic atrial fibrillation at inclusion. The relative risk (and 95% confidence interval) associated with idiopathic atrial fibrillation was 4.22 [2.10-8.47] for cardiovascular mortality (P=0.0001) and 1. 97 [1.14-3.40] for total mortality (P=0.01). When age, systolic blood pressure, cholesterol, body mass index and tobacco consumption were entered into a Cox model, idiopathic atrial fibrillation remained an independent risk factor for cardiovascular (P=0.0008) and total death (P=0.04). CONCLUSION: With a long follow-up period, idiopathic atrial fibrillation was associated with higher mortality in middle aged Frenchmen. Copyright 1999 The European Society of Cardiology.
AIMS: Idiopathic atrial fibrillation describes atrial fibrillation of unknown origin occurring without heart disease. Mortality is considered unaffected by idiopathic atrial fibrillation. We used the long follow-up period (23 years on average) of the Paris Prospective Study I to assess the mortality of idiopathic atrial fibrillation subjects in middle-aged men. METHODS: 7746 working Frenchmen, aged 43-52 in 1967-72, underwent a physical examination plus ECG, answered questionnaires, and provided blood samples. Strict exclusion criteria were used to select idiopathic atrial fibrillation only, and men with known cardiac disease were further excluded from analysis. At 1 January 1994, vital status was unknown for 4.6% of the subjects. The analysis was conducted on the 6722 remaining subjects. RESULTS: Twenty-five subjects had idiopathic atrial fibrillation at inclusion. The relative risk (and 95% confidence interval) associated with idiopathic atrial fibrillation was 4.22 [2.10-8.47] for cardiovascular mortality (P=0.0001) and 1. 97 [1.14-3.40] for total mortality (P=0.01). When age, systolic blood pressure, cholesterol, body mass index and tobacco consumption were entered into a Cox model, idiopathic atrial fibrillation remained an independent risk factor for cardiovascular (P=0.0008) and total death (P=0.04). CONCLUSION: With a long follow-up period, idiopathic atrial fibrillation was associated with higher mortality in middle aged Frenchmen. Copyright 1999 The European Society of Cardiology.
Authors: P Kirchhof; A Goette; G Hindricks; S Hohnloser; K-H Kuck; T Meinertz; U Ravens; G Steinbeck; G Breithardt Journal: Herzschrittmacherther Elektrophysiol Date: 2007-12
Authors: I C van Gelder; V E Hagens; J H Kingma; H A Bosker; O Kamp; T Kingma; N J G M Veeger; J Bouma; E M TenVergert; J G P Tijssen; H J G M Crijns Journal: Neth Heart J Date: 2002-03 Impact factor: 2.380
Authors: D George Wyse; Isabelle C Van Gelder; Patrick T Ellinor; Alan S Go; Jonathan M Kalman; Sanjiv M Narayan; Stanley Nattel; Ulrich Schotten; Michiel Rienstra Journal: J Am Coll Cardiol Date: 2014-02-12 Impact factor: 24.094
Authors: Mariëlle Kloosterman; Jonas Oldgren; David Conen; Jorge A Wong; Stuart J Connolly; Alvaro Avezum; Salim Yusuf; Michael D Ezekowitz; Lars Wallentin; Marie Ntep-Gweth; Philip Joseph; Tyler W Barrett; Supachai Tanosmsup; William F McIntyre; Shun Fu Lee; Ratika Parkash; Guy Amit; Alex Grinvalds; Isabelle C Van Gelder; Jeff S Healey Journal: Europace Date: 2020-06-01 Impact factor: 5.214
Authors: Jose Luis Clua-Espuny; Anna Panisello-Tafalla; Carlos Lopez-Pablo; Inigo Lechuga-Duran; Ramon Bosch-Princep; Jorgina Lucas-Noll; Antonia Gonzalez-Henares; Lluisa Queralt-Tomas; Rosa Ripolles-Vicente; Cristina Calduch-Noll; Nuria Gonzalez-Rojas; Miguel Gallofre-Lopez Journal: Cardiol Res Date: 2014-02-27
Authors: Eun-Jeong Kim; Xiaoyan Yin; João D Fontes; Jared W Magnani; Steve A Lubitz; David D McManus; Sudha Seshadri; Ramachandran S Vasan; Patrick T Ellinor; Martin G Larson; Emelia J Benjamin; Michiel Rienstra Journal: Am Heart J Date: 2016-04-30 Impact factor: 4.749